Company Profile

PFIZER LTD.

NSE : PFIZERBSE : 500680ISIN CODE : INE182A01018Industry : Pharmaceuticals & DrugsHouse : Pfizer - MNC
BSE4182.85-37.65 (-0.89 % )
PREV CLOSE (Rs.) 4220.50
OPEN PRICE (Rs.) 4242.50
BID PRICE (QTY) 0.00 (0 )
OFFER PRICE (QTY) 0.00 (0 )
VOLUME 910
TODAY'S LOW / HIGH (Rs.)4169.10 4260.00
52 WK LOW / HIGH (Rs.)2797.5 4649.4
NSE4187.55 -32.5 (-0.77 % )
PREV CLOSE(Rs.) 4220.05
OPEN PRICE (Rs.) 4230.00
BID PRICE (QTY) 0.00 (0 )
OFFER PRICE (QTY) 4187.55 (23 )
VOLUME 18766
TODAY'S LOW / HIGH(Rs.) 4174.95 4264.50
52 WK LOW / HIGH (Rs.)2792.25 4629.85

Smart Quotes

1D 1M 3M 1Y 3Y 5Y
STOCK SUMMARY
Trade Value (Rs. in Lacs) 0.00
Dividend Yield(%) 0.54
TTM EPS (Rs.) 112.70
P/E Ratio 37.11
Book Value (Rs.) 720.28
Face Value (Rs.) 10
MCap (Rs. in Mn) 191355.90
Price/Earning (TTM) 31.47
Price/Sales (TTM) 8.76
Price/Book (MRQ) 5.81
PAT Margin (%) 20.61
ROCE (%) 23.22
Incorporation Year : 1950

Management Info :

R A Shah - Chairman S Sridhar - Managing Director

Registered Office :

Address : The Capital, 1802/1901,Plot No.c-70, G Block,Bandra Kurla Complex, Bandra (East),
Mumbai,
Maharashtra-400051

Phone : 91 22 6693 2000

Registrar's Details : KFIN Technologies Pvt Ltd.-(Karvy Fintech Pvt Ltd.)
Karvy Selenium Tower B, Plot 31-32,Gachibowli,Financial District,Nanakramguda,Hyderabad
Listing : BSE, NSE, MCX
NEWS More
14Feb02-14-2020$Pfizer informs about issuance of duplicate share certificates Pfizer informs about issuanc

Pfizer has informed that pursuant to Regulation 39(3) and other application regulations of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the Registrar and Transfer Agent of the Company, Kfin Technologies has received requests for issue of duplicate Share Certificates from the Shareholders, Salim Majeed Patel and Arati Roy.

The above information is a part of company’s filings submitted to BSE.

Pfizer has informed that pursuant to Regulation 39(3) and other..
14Feb02-14-2020$Pfizer informs about un-audited financial results Pfizer informs about un-audi

Pursuant to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Pfizer has  informed that the company has submitted the un-audited financial results for the quarter ended December 31, 2019, which were approved by the Board of Directors of the Company at its Meeting held today, that commenced at 12:00 noon and concluded at 2:00 pm. Also the company has enclosed the Limited Review Report by its Auditors Walker Chandiok & Co LLP, in respect of the results.

The above information is a part of company’s filings submitted to BSE.

Pursuant to Regulation 33 of the SEBI (Listing Obligations and..
14Feb02-14-2020$ Announcement under Regulation 30 (LODR)-Change in Directorate Announcement under Regulati
Intimation pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 Appointment of Mr. Samir Kazi as an Executive Director.
Intimation pursuant to Regulation 30 of the SEBI (Listing Oblig..
03Feb02-03-2020$ Board Meeting Intimation for Board Meeting For The Unaudited Financial Results For The Quarter Ended December 31, 2019. Board Meeting Intimation fo
PFIZER LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/02/2020 ,inter alia, to consider and approve This is to inform you that a meeting of the Board of Directors of the Company is scheduled to be held on Friday, February 14, 2020, inter alia, to consider and take on record the Unaudited Financial Results of the Company for the quarter ended December 31, 2019. Pursuant to the "Pfizer Limited - Code of Internal Procedures and Conduct to Regulate, Monitor and Report Trading by Insiders', the Trading Window of the Company remains closed from Wednesday, January 1, 2020 till 48 hours after the results are made public on February 14, 2020. We request you to kindly take the same on record.
PFIZER LTD.has informed BSE that the meeting of the Board of Di..
16Sep09-16-2019$Pfizer informs about disclosure Pfizer informs about disclos

Pfizer has informed about disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (Listing Regulations). 

The above information is a part of company’s filings submitted to BSE.

Pfizer has informed about disclosure under Regulation 30 of the..
Financials More
Rs. in Millions
QTR Dec 19 ANNUAL 19
Net Profit1390.64290.5
Gross Profit 1645 6599.1
Operating Profit 1916.67325.9
Net Sales 5381.820815
ROLLING FORWARD P/E (EOD)
EVENT CALENDAR
peer group More
Sanofi India (BSE)
 7322.90 (2.05%)
M.Cap ( in Cr)
16865.09
Ajanta Pharma (BSE)
 1446.05 (10.03%)
M.Cap ( in Cr)
12618.42
Ipca Laboratories (BSE)
 1456.15 (3.43%)
M.Cap ( in Cr)
18398.76
Solara Active Pharma (BSE)
 680.25 (6.01%)
M.Cap ( in Cr)
1772.41
Alkem Laboratories (BSE)
 2657.75 (1.39%)
M.Cap ( in Cr)
31777.39
Shareholding Pattern More
MUTUAL FUNDS/UTI 9.45 %
PROMOTERS 63.92 %
FI/BANKS/INSURANCE 3.27 %
NON-INSTITUTION 19.36 %
FII 0 %
GOVERNMENT 0 %
F & O Quotes